Cambridge Innovation Capital appoints Dr Andrew Williamson as Investment Director

Cambridge Innovation Capital appoints Dr Andrew Williamson as Investment Director

By Rachel Holdsworth - 05 December 2016

Cambridge Innovation Capital plc (“CIC”), a Cambridge-based investor in technology and healthcare companies, is pleased to announce the appointment of Dr Andrew Williamson as an Investment Director.

Andrew joins CIC from True North Venture Partners in Chicago where he was a partner in its $300 million venture fund. Prior to this, Andrew spent ten years leading materials science and semiconductor research in US government research laboratories, followed by managing director positions at venture capital funds, Physic Ventures in San Francisco, and MalibuIQ in Los Angeles.

Andrew studied at the University of Cambridge as both an undergraduate and a graduate, receiving an MA in Natural Sciences and a PhD in Physics. Andrew also holds an MBA from the Haas School of Business at the University of California, Berkeley.

Victor Christou, Chief Executive Officer of CIC, said, “We are very pleased to welcome someone of Andrew’s experience and calibre to the CIC team. He brings a perfect combination of the ideal attributes for a CIC Investment Director with hands-on experience building deep technology businesses, coupled with a venture investing background and an understanding of Cambridge and its academic institutes. Taken together, these position him ideally for a role investing in the most exciting cluster in Europe.”

Andrew Williamson added, “It is wonderful to be returning to Cambridge and to be joining such an impressive organisation and team. There is an enormous number of potentially world-leading businesses emerging from the Cambridge Cluster. Working at CIC will provide me with a great opportunity to work with these businesses to grow them into the global category leaders of the future."

Related Items

More from
Cambridge Innovation Capital

EU Cookie Law

This site uses cookies to enable it to run and by using the site you are consenting to this, more about how we use cookies